Morgan Stanley Phibro Animal Health Corp Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Phibro Animal Health Corp stock. As of the latest transaction made, Morgan Stanley holds 489,015 shares of PAHC stock, worth $11.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

489,015

Previous 530,791 7.87%

Holding current value

$11.1 Million

Previous $11.9 Million 14.01%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$20.89 - $25.55 $872,700 - $1.07 Million	-41,776 Reduced 7.87%	489,015 $10.3 Million
Q3 2024 Nov 14, 2024	BUY	$16.39 - $22.5 $1.39 Million - $1.91 Million	84,964 Added 19.06%	530,791 $11.9 Million
Q2 2024 Oct 17, 2024	SELL	$12.44 - $18.55 $461,785 - $688,594	-37,121 Reduced 7.69%	445,827 $7.48 Million
Q2 2024 Aug 14, 2024	SELL	$12.44 - $18.55 $461,785 - $688,594	-37,121 Reduced 7.69%	445,827 $7.48 Million
Q1 2024 Oct 17, 2024	BUY	$10.63 - $13.68 $394,596 - $507,815	37,121 Added 8.33%	482,948 $6.24 Million
Q1 2024 Aug 16, 2024	BUY	$10.63 - $13.68 $1.01 Million - $1.3 Million	94,779 Added 24.42%	482,948 $6.24 Million
Q1 2024 May 15, 2024	BUY	$10.63 - $13.68 $1.01 Million - $1.3 Million	94,779 Added 24.42%	482,948 $6.24 Million
Q4 2023 Aug 16, 2024	SELL	$9.59 - $12.91 $552,940 - $744,364	-57,658 Reduced 12.93%	388,169 $4.49 Million
Q4 2023 Feb 13, 2024	SELL	$9.59 - $12.91 $941,085 - $1.27 Million	-98,132 Reduced 20.18%	388,169 $4.49 Million
Q3 2023 Nov 15, 2023	BUY	$12.43 - $15.29 $433,570 - $533,330	34,881 Added 7.73%	486,301 $6.21 Million
Q2 2023 Aug 14, 2023	BUY	$12.92 - $15.89 $256,642 - $315,638	19,864 Added 4.6%	451,420 $6.18 Million
Q1 2023 May 15, 2023	SELL	$13.67 - $16.37 $493,240 - $590,662	-36,082 Reduced 7.72%	431,556 $6.61 Million
Q4 2022 Feb 14, 2023	BUY	$12.05 - $15.14 $2.21 Million - $2.78 Million	183,420 Added 64.53%	467,638 $6.27 Million
Q3 2022 Nov 14, 2022	BUY	$12.82 - $20.22 $560,746 - $884,422	43,740 Added 18.19%	284,218 $3.78 Million
Q2 2022 Oct 27, 2022	BUY	$17.89 - $20.47 $2.26 Million - $2.59 Million	126,352 Added 110.71%	240,478 $4.6 Million
Q2 2022 Aug 15, 2022	BUY	$17.89 - $20.47 $2.26 Million - $2.59 Million	126,352 Added 110.71%	240,478 $4.6 Million
Q1 2022 Oct 27, 2022	SELL	$18.39 - $21.85 $2.32 Million - $2.76 Million	-126,352 Reduced 52.54%	114,126 $2.28 Million
Q1 2022 May 13, 2022	BUY	$18.39 - $21.85 $240,412 - $285,645	13,073 Added 12.94%	114,126 $2.28 Million
Q4 2021 Feb 14, 2022	SELL	$18.96 - $22.76 $247,428 - $297,018	-13,050 Reduced 11.44%	101,053 $2.06 Million
Q3 2021 Nov 15, 2021	BUY	$20.59 - $30.01 $2.35 Million - $3.42 Million	114,103 New	114,103 $2.46 Million

Others Institutions Holding PAHC

# of Institutions

176

Shares Held

20.7M

Call Options Held

Put Options Held

View Full List

About PHIBRO ANIMAL HEALTH CORP

Ticker PAHC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,337,600
Market Cap $462M
Description
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...

More about PAHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account